Pharmaceutical products without proper labelling impact patient safety, and the lack of temperature monitoring during storage and transport impacts the efficiency of those products. To mitigate those two major risks, it is necessary to apply labels directly to the product and document transport and storage conditions during the entire supply chain.
To solve those two important challenges Faubel and ELPRO are offering a new joint solution: the Faubel-Compact® Label for multi-language product labelling with an integrated state-of-the-art LIBERO ITS (indicator tab start) temperature indicator from ELPRO.
With a robust battery life of four years, LIBERO ITS enables seamless, end-to-end temperature monitoring on box or kit level. According to Martin Peter, head of strategy and marketing at ELPRO, the new indicators are key. "LIBERO ITS offers end-to-end safety for a drug supply chain with growing complexities including several transport legs, storage situations and many involved parties."
The temperature indicator is applied directly to the Faubel-Compact® Label and stays on the product from filling to the patient. LIBERO ITS monitors temperature deviations and constantly manages the remaining stability budget. The status can be viewed at any time by simply pressing a button. In addition, all available statistics can be downloaded and documented to a smartphone app. A cloud database allows central and secure archiving of the data.
Compared to traditional data loggers, LIBERO ITS is much thinner and smaller at 3 x 30 x 30mm. It can be easily integrated into a Faubel-Compact® Label. Therefore, the booklet label including the temperature indicator can be applied in one simple action during the filling, packaging and labelling process: a two-in-one solution saving time and gaining efficiency. This solution can be adapted to various containers. For example, as a wrap-around solution for syringes or as a flag-label for vials.
"Our Faubel-Compact® Label combined with the temperature indicator LIBERO ITS is the ideal solution for pharmaceutical products and fits very well with our portfolio of smart labels." says Frank Jäger, managing director at Faubel.